A Study to Learn How Safe, Tolerable and Capable of Producing an Immune Response is, a Modified RNA Vaccine Against Pandemic Influenza
Conditions: Grippe; Influenza; Vaccines Interventions: Biological: PF-07985819 pdmFlu Vaccine; Biological: Placebo; Biological: Quadrivalent influenza vaccine (QIV) Sponsors: Pfizer Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Bird Flu | Bird Flu (H5N1 Avian Influenza) Vaccine | Flu Pandemic | Influenza | Influenza Vaccine | Learning | Pandemics | Pfizer | Research | Study | Universities & Medical Training | Vaccines